Unverified Reports 未经核实报告

Market talk about listed companies, with each company's answer.
上市公司市场传闻及公司回应。

911 candidate claims 候选记录

Read This First 重要提示

These claims are unverified. Do not trade on this page. 以下传闻均未经核实，请勿据此交易。

Coverage 覆盖范围

Source 来源	Last Run 最近运行	Read 读取	On Claims 在列	Note 备注
SZSE Q&A Board 互动易	26 Sep 2026 04:50	578	605
SSE Q&A Board 上证e互动	26 Sep 2026 04:50	24	121
Jiuyan Gongshe 韭研公社	26 Sep 2026 04:51	38	8	2 logged but on no claim 已记录但未关联传闻
Clarification Filings 澄清公告	26 Sep 2026 04:51	52	50	From the Disclosure Wire 来自披露日志 · 1 logged but on no claim 已记录但未关联传闻
Volatility Statements 股票交易异常波动公告	26 Sep 2026 05:00	—	73
Tonghuashun Newswire 同花顺 7x24	26 Sep 2026 05:00	200	22
Sina Finance Newswire 新浪财经 7x24	26 Sep 2026 05:01	900	3
The Standard	26 Sep 2026 05:01	1,000	10
Jiemian News 界面新闻	26 Sep 2026 05:02	54	48
cninfo_clarify	26 Sep 2026 04:51	—	0	0 held
Substack	26 Sep 2026 05:02	—	0	227 held

Not read (robots.txt refuses our crawler by name): Maimai 脉脉 and Xueqiu 雪球. Refused by the site: Weibo 微博 (needs a signed-in account) and Zhihu 知乎 (needs a signed-in account). Reachable but not read: Reddit (needs a registered Reddit API app).

Order 排序Impact 影响Company’s Answer 公司回复Seen On 来源Why Logged 收录依据

1 of 911 candidate claims 候选传闻 · highest impact first 按影响排序

Showing the claims that name Apeloa Pharmaceutical 普洛药业. 仅显示提及该公司的传闻。 Show every company 全部

Medium 中等 · 36 Unverified 未经核实 No Clear Answer 未明确表态

First posted 首见 22 Jun 2026 15:26
Logged 记录 19 Sep 2026 04:25

Apeloa Pharmaceutical 普洛药业 000739.SZ

Impact 影响 36 · Share issue, buyback, spin-off or listing 增发/回购/分拆 · Stock +2.6% on 23 Jun 2026 (1.1× its usual move) · Market value ¥293亿

Investor’s Question 投资者提问 · SZSE Q&A Board 互动易 · 22 Jun 2026 15:26 · Source ↗

市场有传言公司司美格鲁肽三期临床试验效果不及预期，公司准备在回购注销方案被股东会通过后正式公告这一消息，进而实现低价回购这一目标，请董秘正面回答这是否为谣言？

Why Logged 收录依据: A rumour word

Company’s Answer 公司回复 · 3 Jul 2026 10:27

投资者您好！公司司美格鲁肽三期临床进展顺利，参见公司“2025年年度报告-管理层讨论与分析-业绩驱动因素-项目投资情况”中的披露内容。该药物完成临床试验后，尚需国家药品监督管理局审评、审批通过后方可上市，药品审评审批时间、审批结果均存在诸多不确定性，敬请广大投资者注意投资风险。另外，公司实施股份回购注销方案，旨在提振投资者信心，进一步回报投资者。在此，郑重提醒投资者：公司指定的信息披露媒体为《证券时报》和巨潮资讯网（www.cninfo.com.cn），公司的信息均以在上述指定媒体披露的信息为准。感谢您的关注！

No Clear Answer 未明确表态 No rule matched 无匹配规则

Corroboration 印证度

1 of 5 sources 信源 · 1 sighting on 1 venue

Seen On 来源

SZSE Q&A Board 互动易

Related Stocks 相关标的

000739.SZ

Our Record 战绩

Logged Since Sep 2026 累计记录 911

Published After Review 已审核发布 0

Resolved True 已证实 0

Resolved False 已证伪 0

Contradicted 已被否认 0

Still Open 未结 911

No claim has been resolved yet, so there is no hit rate. 尚无已结传闻，暂无命中率。

How It Works 说明

How Impact Is Scored 影响评分 →
How Answers Are Read 回复判读 →

How Companies Answered 公司回应

940 sightings, by what the company said.

Denied 否认 84

Answer calls the rumour untrue 回复称不属实 71

Answer says the situation does not exist 回复称不存在该情况 13

Confirmed 确认 4

Answer confirms the matter 回复确认属实 3

Answer opens with yes 回复以“是”开头 1

No Clear Answer 未明确表态 721

No Answer 未回复 49

Not yet answered on a board 49

Clarification Filed 已发澄清公告 50

Company filed a clarification 公司发布澄清公告 50

Not Applicable 不适用 32

From The Standard 来自The Standard, no company to answer 无公司可回复 10

From Jiemian News 界面新闻来自Jiemian News 界面新闻, no company to answer 无公司可回复 8

Community posts 社区帖子, no company to answer 无公司可回复 8

From Tonghuashun Newswire 同花顺 7x24 来自Tonghuashun Newswire 同花顺 7x24, no company to answer 无公司可回复 6

Claims by Venue 来源分布

SZSE Q&A Board 互动易 598 · 65.6%

SSE Q&A Board 上证e互动 118 · 13.0%

Volatility Statements 股票交易异常波动公告 73 · 8.0%

Clarification Filings 澄清公告 50 · 5.5%

Jiemian News 界面新闻 36 · 4.0%

Tonghuashun Newswire 同花顺 7x24 19 · 2.1%

The Standard 10 · 1.1%

Jiuyan Gongshe 韭研公社 5 · 0.5%

Sina Finance Newswire 新浪财经 7x24 2 · 0.2%

Each claim is counted at its first sighting. Robots.txt keeps 2 more venues unread.

Corroboration 印证度

Seen on More Than One Venue 多平台 17

Corroboration Above 1 印证度大于1 5

Repeat Questions 重复提问 10

Clarification Filings Linked 关联澄清公告 73

Same Stock and Venue Within 14 Days 同股同源 317

The score counts independent sources, up to two per venue class, each from a different author. Repeats and company filings do not count. The same rumour asked by different investors on one board is logged as separate claims, so a score above 1 needs a second venue. Scores are out of 5. 得分计独立来源数，每类渠道最多两个且作者不同；重复和公司公告不计。同一传闻由不同投资者在同一平台提问会分别记录，因此 1 分以上需要第二个渠道。满分 5。